An anonymous reader writes "An HIV/AIDS vaccine developed in Ontario has applied for Phase 1 human trials. Safety and immunogenicity studies of the vaccine, dubbed SAV001-H, have already been completed on animals. Phase 1 human trials will check the safety of the vaccine on HIV positive volunteers. Phase 2 will then test immunogenicity."pa href="http://science.slashdot.org/story/09/07/02/192249/HIVAIDS-Vaccine-To-Begin-Phase-I-Human-Trials?from=rss"img src="http://science.slashdot.org/slashdot-it.pl?from=rssamp;op=imageamp;style=h0amp;sid=09/07/02/192249"/a/ppa href="http://science.slashdot.org/story/09/07/02/192249/HIVAIDS-Vaccine-To-Begin-Phase-I-Human-Trials?from=rss"Read more of this story/a at Slashdot./p
pa href="http://feedads.g.doubleclick.net/~at/af9DhU4PXx0lAnJpwZdFYdBr9Wc/0/da"img src="http://feedads.g.doubleclick.net/~at/af9DhU4PXx0lAnJpwZdFYdBr9Wc/0/di" border="0" ismap="true"/img/abr/
a href="http://feedads.g.doubleclick.net/~at/af9DhU4PXx0lAnJpwZdFYdBr9Wc/1/da"img src="http://feedads.g.doubleclick.net/~at/af9DhU4PXx0lAnJpwZdFYdBr9Wc/1/di" border="0" ismap="true"/img/a/pimg src="http://feeds.feedburner.com/~r/Slashdot/slashdotScience/~4/pjmyMXHgNyU" height="1" width="1"/